WHO ICTRP trial
A comparative study of Arogyavardhini Vati orally with Manjishtha Lepa locally…
CTRI/2025/06/088126 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/06/088126 |
|---|---|
| Public title | A comparative study of Arogyavardhini Vati orally with Manjishtha Lepa locally and Manjishtha Lepa only in the management of Vyanga |
| Scientific title | Add on effect of Arogyavardhini vati along with Manjishtha Lepa in comparison with Manjishtha Lepa only in the management of vyanga with special reference to Melasma: A Randomized Controlled Trial - NIL |
| Primary sponsor | Dr. Shweta Rajendra Raisane |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: L814- Other melanin hyperpigmentation |
| Registration date | Mar 6, 2025 |
| Target size | 40 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: